Cargando…

Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey

INTRODUCTION: The uptake of human papillomavirus (HPV) vaccination in France remains low. The aim of this study was to identify factors associated with the uptake of the HPV vaccine in girls aged 11–14 years in France. METHODS: We conducted a telephone survey among a quota sample of 1102 mothers of...

Descripción completa

Detalles Bibliográficos
Autores principales: Dib, Fadia, Mayaud, Philippe, Renaudie, Cécile, Launay, Odile, Chauvin, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621050/
https://www.ncbi.nlm.nih.gov/pubmed/35766886
http://dx.doi.org/10.1080/21645515.2022.2083894
_version_ 1784821452280692736
author Dib, Fadia
Mayaud, Philippe
Renaudie, Cécile
Launay, Odile
Chauvin, Pierre
author_facet Dib, Fadia
Mayaud, Philippe
Renaudie, Cécile
Launay, Odile
Chauvin, Pierre
author_sort Dib, Fadia
collection PubMed
description INTRODUCTION: The uptake of human papillomavirus (HPV) vaccination in France remains low. The aim of this study was to identify factors associated with the uptake of the HPV vaccine in girls aged 11–14 years in France. METHODS: We conducted a telephone survey among a quota sample of 1102 mothers of 11-14-year-old daughters residing in mainland France, using the French Survey Questionnaire for the Determinants of HPV Vaccine Hesitancy (FSQD-HPVH). The dependent variable was the uptake of at least one dose of the HPV vaccine in the daughter. The independent variables included the FSQD-HPVH item variables, the Global Vaccine Confidence Index item variables, the daughter’s age, and the mother’s socioeconomic status. RESULTS: Overall, 38.6% of the mothers indicated that their daughter received at least one dose of the HPV vaccine. The multivariate analysis revealed that agreeing with the statement that doctors/health care providers believe vaccinating girls against HPV was a good idea, and having asked questions to the attending doctor about HPV vaccines were associated with a higher HPV vaccine uptake (OR = 4.99 , 95% CI [2.09–11.89]; and OR = 3.44, 95% CI [2.40–4.92]). Mother’s belief that her daughter was too young to be vaccinated against HPV (OR = 0.16 , 95% CI [0. 09–0.29]) and lower daughter’s age (OR = 0.17 , 95% CI [0.10–0.28] for girls aged 11 compared to those aged 14) were found strongly inversely associated with HPV vaccination, followed by agreeing with the statement that the HPV vaccine was unsafe (OR = 0.42 , 95% CI [0.26–0.67]), identifying as true the statement that HPV was very rare (OR = 0.49 , 95% CI [0.31–0.77]), and the mother’s refusal of own vaccination (OR = 0.57 , 95% CI [0.40–0.80]). CONCLUSION: We have identified important determinants associated with HPV vaccine uptake in France. Interventions designed to improve HPV vaccine uptake should be tailored to address these determinants.
format Online
Article
Text
id pubmed-9621050
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-96210502022-11-01 Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey Dib, Fadia Mayaud, Philippe Renaudie, Cécile Launay, Odile Chauvin, Pierre Hum Vaccin Immunother HPV – Research Paper INTRODUCTION: The uptake of human papillomavirus (HPV) vaccination in France remains low. The aim of this study was to identify factors associated with the uptake of the HPV vaccine in girls aged 11–14 years in France. METHODS: We conducted a telephone survey among a quota sample of 1102 mothers of 11-14-year-old daughters residing in mainland France, using the French Survey Questionnaire for the Determinants of HPV Vaccine Hesitancy (FSQD-HPVH). The dependent variable was the uptake of at least one dose of the HPV vaccine in the daughter. The independent variables included the FSQD-HPVH item variables, the Global Vaccine Confidence Index item variables, the daughter’s age, and the mother’s socioeconomic status. RESULTS: Overall, 38.6% of the mothers indicated that their daughter received at least one dose of the HPV vaccine. The multivariate analysis revealed that agreeing with the statement that doctors/health care providers believe vaccinating girls against HPV was a good idea, and having asked questions to the attending doctor about HPV vaccines were associated with a higher HPV vaccine uptake (OR = 4.99 , 95% CI [2.09–11.89]; and OR = 3.44, 95% CI [2.40–4.92]). Mother’s belief that her daughter was too young to be vaccinated against HPV (OR = 0.16 , 95% CI [0. 09–0.29]) and lower daughter’s age (OR = 0.17 , 95% CI [0.10–0.28] for girls aged 11 compared to those aged 14) were found strongly inversely associated with HPV vaccination, followed by agreeing with the statement that the HPV vaccine was unsafe (OR = 0.42 , 95% CI [0.26–0.67]), identifying as true the statement that HPV was very rare (OR = 0.49 , 95% CI [0.31–0.77]), and the mother’s refusal of own vaccination (OR = 0.57 , 95% CI [0.40–0.80]). CONCLUSION: We have identified important determinants associated with HPV vaccine uptake in France. Interventions designed to improve HPV vaccine uptake should be tailored to address these determinants. Taylor & Francis 2022-06-29 /pmc/articles/PMC9621050/ /pubmed/35766886 http://dx.doi.org/10.1080/21645515.2022.2083894 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle HPV – Research Paper
Dib, Fadia
Mayaud, Philippe
Renaudie, Cécile
Launay, Odile
Chauvin, Pierre
Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey
title Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey
title_full Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey
title_fullStr Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey
title_full_unstemmed Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey
title_short Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey
title_sort determinants of human papillomavirus (hpv) vaccine uptake among girls in france: a population-based telephone survey
topic HPV – Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621050/
https://www.ncbi.nlm.nih.gov/pubmed/35766886
http://dx.doi.org/10.1080/21645515.2022.2083894
work_keys_str_mv AT dibfadia determinantsofhumanpapillomavirushpvvaccineuptakeamonggirlsinfranceapopulationbasedtelephonesurvey
AT mayaudphilippe determinantsofhumanpapillomavirushpvvaccineuptakeamonggirlsinfranceapopulationbasedtelephonesurvey
AT renaudiececile determinantsofhumanpapillomavirushpvvaccineuptakeamonggirlsinfranceapopulationbasedtelephonesurvey
AT launayodile determinantsofhumanpapillomavirushpvvaccineuptakeamonggirlsinfranceapopulationbasedtelephonesurvey
AT chauvinpierre determinantsofhumanpapillomavirushpvvaccineuptakeamonggirlsinfranceapopulationbasedtelephonesurvey